Anti-GM1 (IgG + IgA)

Optimal Result: 0.1 - 10 Units.

Detection of ganglioside M1 (GM1) antibodies, usually of the IgM isotype, is associated with multi-focal motor neuropathy and lower motor neuropathy, characterized by muscle weakness and atrophy. Multi-focal motor neuropathy may occur with or without high serum titers of anti-GM1 antibodies. GM1 antibodies are detected in approximately 50 % of persons with multi-focal motor neuropathy.

What is multi-focal motor neuropathy?

Multifocal motor neuropathy is a progressive muscle disorder characterized by weakness in the hands, with differences from one side of the body to the other in the specific muscles involved. It affects men much more than women. Symptoms also include:

  • Muscle wasting
  • Cramping
  • Involuntary contractions or twitching of the leg muscles

The disorder is sometimes mistaken for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. But unlike ALS, multifocal motor neuropathy is treatable. An early and accurate diagnosis allows individuals to recover quickly.

Treatment for multifocal motor neuropathy varies. Some people experience only mild symptoms and do not require treatment. For others, treatment generally consists of intravenous immunoglobulin (IVIg) or immunosuppressive therapy with cyclophosphamide.

Improvement in muscle strength usually begins within three to six weeks after treatment is started. Most who receive treatment early experience little, if any, disability. However, there is evidence of slow progression over many years.

References:

https://www.ninds.nih.gov/health-information/disorders/multifocal-motor-neuropathy#:~:text=Multifocal%20motor%20neuropathy%20is%20a,Muscle%20wasting

What does it mean if your Anti-GM1 (IgG + IgA) result is too high?

Detection of ganglioside M1 (GM1) antibodies, usually of the IgM isotype, is associated with multi-focal motor neuropathy and lower motor neuropathy, characterized by muscle weakness and atrophy. Multi-focal motor neuropathy may occur with or without high serum titers of anti-GM1 antibodies. GM1 antibodies are detected in approximately 50 % of persons with multi-focal motor neuropathy.

10 000+ happy customers
100% satisfaction
★ ★ ★ ★ ★ customer support

Trust us to examine your lab results, guiding you towards improved health.

Use promo code to save 10% off any plan.


We implement proven measures to keep your data safe.

At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.